Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.64 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.64 |
| ▸ | HSD17B1 | P14061 | 8/20 | 0.58 |
| ▸ | HSD17B2 | P37059 | 8/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.58 |
| ▸ | CYP2B6 | P20813 | 4/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.50 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.46 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22639444 | 0.93 | ALOX5 (0.58) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL5426888 | 0.82 | ESR1 (0.90) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL19547909 | 0.82 | ESR1 (0.67) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL5005580 | 0.81 | HSD17B1 (0.59) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL619730 | 0.81 | ESR1 (0.61) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL22795574 | 0.80 | ALOX5 (0.60) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL10871253 | 0.80 | ESR1 (0.59) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL20405192 | 0.79 | HPRT1 (0.46) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL19336433 | 0.79 | HPRT1 (0.64) | ESR1ESR2CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL24804768 | 0.79 | ESR1 (0.50) | ESR1ESR2HSD17B1HSD17B2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3372593-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-12-23 | — | — | EP | disclosed |
| US-10833278-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10833278-B2 | Compound and organic light emitting device comprising the same | CRY1, CRY2, ORC3 | ESR1 53/4885ESR2 685/4885HSD17B1 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.